Altimmune Inc (ALT)
8.64
+0.59
(+7.33%)
USD |
NASDAQ |
Nov 21, 14:08
Altimmune Price: 8.64 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 7.61 | 8.420 | 7.519 | 8.05 | 4.714M |
| Nov 19, 2024 | 7.04 | 7.48 | 6.981 | 7.47 | 2.811M |
| Nov 18, 2024 | 7.55 | 7.59 | 6.945 | 7.15 | 4.486M |
| Nov 15, 2024 | 8.27 | 8.54 | 7.455 | 7.61 | 5.413M |
| Nov 14, 2024 | 9.55 | 9.70 | 8.33 | 8.455 | 5.190M |
| Nov 13, 2024 | 9.75 | 11.16 | 9.46 | 9.52 | 10.09M |
| Nov 12, 2024 | 7.62 | 10.02 | 7.46 | 9.49 | 18.68M |
| Nov 11, 2024 | 7.89 | 7.96 | 6.92 | 7.35 | 4.785M |
| Nov 08, 2024 | 7.45 | 7.68 | 7.365 | 7.68 | 1.938M |
| Nov 07, 2024 | 7.75 | 8.05 | 7.40 | 7.46 | 4.234M |
| Nov 06, 2024 | 7.26 | 7.41 | 7.082 | 7.31 | 2.677M |
| Nov 05, 2024 | 6.76 | 7.03 | 6.64 | 7.03 | 1.681M |
| Nov 04, 2024 | 6.69 | 6.835 | 6.45 | 6.79 | 2.063M |
| Nov 01, 2024 | 6.82 | 7.20 | 6.62 | 6.74 | 2.128M |
| Oct 31, 2024 | 6.74 | 6.855 | 6.58 | 6.74 | 1.666M |
| Oct 30, 2024 | 7.28 | 7.31 | 6.74 | 6.76 | 2.311M |
| Oct 29, 2024 | 7.04 | 7.575 | 6.85 | 7.36 | 3.574M |
| Oct 28, 2024 | 6.82 | 7.185 | 6.765 | 7.01 | 1.860M |
| Oct 25, 2024 | 6.85 | 7.05 | 6.69 | 6.69 | 1.308M |
| Oct 24, 2024 | 6.74 | 6.965 | 6.65 | 6.765 | 1.481M |
| Oct 23, 2024 | 6.74 | 6.85 | 6.52 | 6.72 | 1.467M |
| Oct 22, 2024 | 6.90 | 6.96 | 6.67 | 6.80 | 917153.0 |
| Oct 21, 2024 | 6.90 | 6.97 | 6.63 | 6.90 | 1.214M |
| Oct 18, 2024 | 6.79 | 7.11 | 6.66 | 6.88 | 1.379M |
| Oct 17, 2024 | 6.84 | 7.14 | 6.709 | 6.79 | 1.468M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.62
Minimum
Nov 22 2019
33.26
Maximum
Jul 20 2020
9.225
Average
8.89
Median
Mar 27 2024
Price Benchmarks
| Eli Lilly and Co | 749.85 |
| Viking Therapeutics Inc | 52.90 |
| Amgen Inc | 290.15 |
| Avid Bioservices Inc | 12.24 |
| NovaBay Pharmaceuticals Inc | 0.70 |
Price Related Metrics
| PS Ratio | 11269.83 |
| PEG Ratio | -2.825 |
| Price to Book Value | 4.607 |
| Earnings Yield | -18.17% |
| Market Cap | 614.52M |